Gene · 64132
Papers4,070
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,070
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Xylosyltransferase Bump-and-hole Engineering to Chemically Manipulate Proteoglycans in Mammalian Cells. | bioRxiv | 2024 | 38979271 | PubTator, text mining | PubMed |
| Editorial: The Global Threats of Increasing Antimicrobial Resistance Require New Approaches to Drug Development, Including Molecular Antimicrobial Adjuvants. | Med Sci Monit | 2024 | 38967286 | PubTator, text mining | PubMed |
| The F plasmid conjutome: the repertoire of E. coli proteins translocated through an F-encoded type IV secretion system. | mSphere | 2024 | 38940509 | PubTator, text mining | PubMed |
| Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance. | Chem Sci | 2024 | 38939155 | PubTator, text mining | PubMed |
| Bimodality in Ras signaling originates from processivity of the Ras activator SOS without deterministic bistability. | Sci Adv | 2024 | 38905351 | PubTator, text mining | PubMed |
| Tactical terminase: How a Salmonella prophage navigates oxidative stress. | Cell Host Microbe | 2024 | 38870894 | PubTator, text mining | PubMed |
| Targeting the RAS upstream and downstream signaling pathway for cancer treatment. | Eur J Pharmacol | 2024 | 38866361 | PubTator, text mining | PubMed |
| LexA, an SOS response repressor, activates TGase synthesis in Streptomyces mobaraensis. | Front Microbiol | 2024 | 38855760 | PubTator, text mining | PubMed |
| Spondyloocular Syndrome: First Case of Rare Osseous and Ocular Syndrome from India with Novel Mutation and Expanded Phenotypic Spectrum. | Calcif Tissue Int | 2024 | 38829420 | PubTator, text mining | PubMed |
| A genome-scale screen identifies sulfated glycosaminoglycans as pivotal in epithelial cell damage by Candida albicans. | bioRxiv | 2024 | 38826446 | PubTator, text mining | PubMed |
| Phagosomal granulocytic ROS in septic patients induce the bacterial SOS response. | iScience | 2024 | 38799552 | PubTator, text mining | PubMed |
| Understanding Stimulation of Conjugal Gene Transfer by Nonantibiotic Compounds: How Far Are We? | Environ Sci Technol | 2024 | 38753980 | PubTator, text mining | PubMed |
| Identification of core genes involved in the response of Apocynum venetum to salt stress based on transcriptome sequencing and WGCNA. | PLoS One | 2024 | 38687723 | PubTator, text mining | PubMed |
| Variation of the Start Date of the Vegetation Growing Season (SOS) and Its Climatic Drivers in the Tibetan Plateau. | Plants (Basel) | 2024 | 38674475 | PubTator, text mining | PubMed |
| Moving toward the Inclusion of Epigenomics in Bacterial Genome Evolution: Perspectives and Challenges. | Int J Mol Sci | 2024 | 38674013 | PubTator, text mining | PubMed |
| Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain. | Antioxidants (Basel) | 2024 | 38671835 | PubTator, text mining | PubMed |
| Biomolecular Condensates Decipher Molecular Codes of Cell Fate: From Biophysical Fundamentals to Therapeutic Practices. | Int J Mol Sci | 2024 | 38612940 | PubTator, text mining | PubMed |
| SOS-Inducing Drugs Trigger Nucleic Acid Release and Biofilm Formation in Gram-Negative Bacteria. | Biomolecules | 2024 | 38540741 | PubTator, text mining | PubMed |
| Xylosyltransferase-Deficiency in Human Dermal Fibroblasts Induces Compensatory Myofibroblast Differentiation and Long-Term ECM Reduction. | Biomedicines | 2024 | 38540185 | PubTator, text mining | PubMed |
| Exploring the links between SOS response, mutagenesis, and resistance during the recovery period. | Antimicrob Agents Chemother | 2024 | 38534113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64132/papers?page=8